Covered recipient · General Payments record
VISHAKHADATTA MATHUR KUMARASWAMY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,167.48
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $485.04 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $167.05 | 7 |
| ARGENX US, INC. | $110.51 | 1 |
| CSL Behring | $88.32 | 5 |
| Teva Pharmaceuticals USA, Inc. | $78.42 | 4 |
| CATALYST PHARMACEUTICALS, INC. | $25.74 | 1 |
| Biogen, Inc. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARGENX US, INC. | $110.51 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142121135 | CMS |
| Biogen, Inc. | $15.00 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104834879 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $25.74 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144451237 | CMS |
| CSL Behring | $16.96 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134643133 | CMS |
| CSL Behring | $14.79 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134643155 | CMS |
| CSL Behring | $17.26 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134643165 | CMS |
| CSL Behring | $18.54 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134643191 | CMS |
| CSL Behring | $20.77 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134643263 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.11 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151725830 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.71 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151725848 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151725888 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.78 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151725950 | CMS |
| UCB, Inc. | $22.78 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173368 | CMS |
| UCB, Inc. | $20.23 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173370 | CMS |
| UCB, Inc. | $27.24 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173372 | CMS |
| UCB, Inc. | $25.65 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173374 | CMS |
| UCB, Inc. | $18.04 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173376 | CMS |
| UCB, Inc. | $30.39 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173378 | CMS |
| UCB, Inc. | $22.72 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143173380 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.